These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9533072)

  • 21. Helicobacter pylori.
    Seifrit B
    AORN J; 1997 Mar; 65(3):614-6, 619-20. PubMed ID: 9061156
    [No Abstract]   [Full Text] [Related]  

  • 22. [Helicobacter pylori: can it be a contributing factor in peptic ulcer in childhood?].
    Tovar-Calderón S; Casaubón-Garcín P; Ramírez-Mayans J; Cervantes R
    Bol Med Hosp Infant Mex; 1991 Oct; 48(10):743-8. PubMed ID: 1764199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
    Laine L; Estrada R; Trujillo M; Emami S
    Am J Gastroenterol; 1997 Dec; 92(12):2213-5. PubMed ID: 9399755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Helicobacter pylori and peptic ulcer--1995 therapeutic indications and recommendations of a Munster Expert Group].
    Domschke W; Dettmer A; Fenner T; Gregor M; Hesse P; Holtmann G; van Husen N; Miederer SE; Schentke KU; Schütz E
    Z Gastroenterol; 1995 Oct; 33(10):598-601. PubMed ID: 7502553
    [No Abstract]   [Full Text] [Related]  

  • 25. Eczema responsive to treatment for Helicobacter pylori.
    Wilson WH
    Ann Allergy Asthma Immunol; 1995 Sep; 75(3):290. PubMed ID: 7552934
    [No Abstract]   [Full Text] [Related]  

  • 26. Barry Marshall, MD: H pylori 35 Years Later.
    Abbasi J
    JAMA; 2017 Apr; 317(14):1400-1402. PubMed ID: 28399250
    [No Abstract]   [Full Text] [Related]  

  • 27. Double-blind randomized trial of bismuth subsalicylate and clindamycin for treatment of Helicobacter pylori infection.
    Westblom TU; Madan E; Subik MA; Duriex DE; Midkiff BR
    Scand J Gastroenterol; 1992; 27(3):249-52. PubMed ID: 1502490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent advances in peptic ulcer disease: Helicobacter pylori infection and its treatment.
    Podolski JL
    Gastroenterol Nurs; 1996; 19(4):128-36. PubMed ID: 8852158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peptic ulcer treatment today--is there a role for maintenance therapy?
    Breslin NP; O'Morain C
    Ital J Gastroenterol Hepatol; 1997 Apr; 29(2):116-21. PubMed ID: 9646190
    [No Abstract]   [Full Text] [Related]  

  • 30. The pharmacoeconomic impact of antimicrobial therapy for peptic ulcer disease in a large urban jail.
    Shuter J; Fletcher DD; Simone VJ; Bellin EY
    J Urban Health; 1998 Dec; 75(4):896-902. PubMed ID: 9854250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of metronidazole, tetracycline, and bismuth-metronidazole-tetracycline triple therapy in the Helicobacter pylori SS1 mouse model after 1 day of dosing: development of an H. pylori lead selection model.
    Sizemore CF; Quispe JD; Amsler KM; Modzelewski TC; Merrill JJ; Stevenson DA; Foster LA; Slee AM
    Antimicrob Agents Chemother; 2002 May; 46(5):1435-40. PubMed ID: 11959579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis and treatment of Helicobacter pylori infection.
    Bytzer P; Dahlerup JF; Eriksen JR; Jarbøl DE; Rosenstock S; Wildt S;
    Dan Med Bull; 2011 Apr; 58(4):C4271. PubMed ID: 21466771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New concepts concerning management of Helicobacter pylori infection: 2 years after the Maastricht Consensus Report.
    Gasbarrini G; Malfertheiner P; Deltenre M; Mégraud F; O'Morain C; Pajares-García J; Quina M; Bianchi Porro G; Gasbarrini A; Franceschi F; Armuzzi A; Cammarota G; Anti M; Pretolani S
    Ital J Gastroenterol Hepatol; 1998 Oct; 30 Suppl 3():S244-7. PubMed ID: 10077746
    [No Abstract]   [Full Text] [Related]  

  • 34. Bismuth subsalicylate instead of metronidazole with lansoprazole and clarithromycin for Helicobacter pylori infection: a randomized trial.
    Chey WD; Fisher L; Elta GH; Barnett JL; Nostrant T; DelValle J; Hasler WL; Scheiman JM
    Am J Gastroenterol; 1997 Sep; 92(9):1483-6. PubMed ID: 9317068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quadruple therapy: the golden bullet or a drug too far?
    Moayyedi P
    Helicobacter; 1996 Jun; 1(2):123-4. PubMed ID: 9398891
    [No Abstract]   [Full Text] [Related]  

  • 36. Gastroduodenal mucosal prostaglandin generation in patients with Helicobacter pylori before and after treatment with bismuth subsalicylate.
    Avunduk C; Suliman M; Gang D; Polakowski N; Eastwood GL
    Dig Dis Sci; 1991 Apr; 36(4):431-4. PubMed ID: 2007360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Characteristics of the effects of de-nol on the course of erosive-ulcerative lesions of the esophagus, stomach and duodenum associated with Helicobacter pylori].
    Grebenev AL; Miagkova LP; Golochevskaia VS; Lapina TL; Sklianskaia OA
    Klin Med (Mosk); 1995; 73(2):34-7. PubMed ID: 7609414
    [No Abstract]   [Full Text] [Related]  

  • 38. Helicobacter pylori infection.
    Suerbaum S; Michetti P
    N Engl J Med; 2002 Oct; 347(15):1175-86. PubMed ID: 12374879
    [No Abstract]   [Full Text] [Related]  

  • 39. Reflections on gastric ulcer disease.
    Tytgat GN
    Eur J Gastroenterol Hepatol; 1996 Apr; 8(4):333-4. PubMed ID: 8781900
    [No Abstract]   [Full Text] [Related]  

  • 40. One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: a prospective randomized controlled trial.
    Kung NN; Sung JJ; Yuen NW; Li TH; Ng PW; Lai WM; Lui YH; Lam KN; Choi CH; Leung EM
    Am J Gastroenterol; 1999 Mar; 94(3):721-4. PubMed ID: 10086657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.